A new selective histamine H1 receptor and platelet-activating factor antagonist, shown to be an effective and generally well-tolerated treatment for allergic rhinitis and chronic urticaria.
A suitable first line anti-histamine that is used to improve the symptoms of Allergic rhinitis.
Safe with a low incidence of side effects and effectively controls persistent allergic rhinitis.
Used for the management of diseases with allergic inflammatory conditions, such as seasonal and perennial rhinitis and helps improve the nasal and non-nasal symptoms.
Become a PCD Pharma Franchise Owner
Start your own PCD Pharma Franchise in your region by becoming a partner with a Trusted PCD Pharma Franchise Partner. Apply now and our expert team will reach out to you!
[wpforms id=”3367″]
After downloading this form you will receive our product list.